Plancorp LLC
MRNA icon

Plancorp LLC’s Moderna MRNA Stock Holding History

Plancorp LLC’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$241K Buy
+1,088
New +$117K 0.01% 397

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
Beau Ventures
Beau Ventures Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Plancorp LLC's MRNA Position: Q3 2026 in Review

Plancorp LLC opened a new position in Moderna (MRNA) in Q3 2026: 1,088 shares worth $241K. The stake represents 0.01% of the portfolio and ranks #397 among its holdings.

582 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Plancorp LLC held 1,088 shares of Moderna worth $241K as of Q3 2026.
  • Moderna was a new Plancorp LLC position in Q3 2026.
  • Moderna made up 0.01% of Plancorp LLC's portfolio in Q3 2026, its #397 holding.
  • 582 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Plancorp LLC's 13F filing for Q3 2026, filed 3 Nov 2026.